You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

newly diagnosed AML

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax in combination with azacitidine and CAG
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 20, 2022

    Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

    Recruiting
    • Acute Myeloid Leukemia
    • Azacitidine Combined With Venetoclax and ATRA group
    • Suzhou, China
      the First Affiliated Hospital of Soochow University
    Dec 8, 2022

    Acute Myeloid Leukemia Trial in Tampa (Vyxeos, Gemtuzumab Ozogamicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 23, 2022

    AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

    Recruiting
    • AML, Adult
    • Chicago, Illinois
    • +1 more
    Aug 17, 2022

    AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

    Not yet recruiting
    • AML, Adult
    • Amersfoort, Netherlands
    • +17 more
    Aug 23, 2023

    Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

    Not yet recruiting
    • Acute Myeloid Leukemia in Children
    • Standard Intervention
    • Investigational Intervention
    • (no location specified)
    Aug 8, 2023

    Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

    Withdrawn
    • Acute Myeloid Leukemia
    • (no location specified)
    May 18, 2022

    AML, Hyperleukocytosis Trial in Monterrey (Vinblastine, Hydroxyurea capsules)

    Recruiting
    • AML
    • Hyperleukocytosis
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Oct 9, 2021

    AML Trial (APVO436)

    Withdrawn
    • AML
    • APVO436
    • (no location specified)
    Nov 29, 2021

    AML Trial in Monterrey (Venetoclax 100 MG, Itraconazole capsule, Azacitidine Injection)

    Recruiting
    • AML
    • Venetoclax 100 MG
    • +2 more
    • Monterrey, Nuevo LEON, Mexico
      Andres Gomez
    Sep 7, 2021

    Acute Myeloid Leukemia, Adult Trial in Hanzhou (Clifutinib Besylate)

    Not yet recruiting
    • Acute Myeloid Leukemia, Adult
    • Clifutinib Besylate
    • Hanzhou, China
      the First Affiliated Hospital,College of Medicine,Zhejiang Unive
    May 4, 2022

    Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Berlin, Germany
    • +9 more
    Jan 13, 2023

    UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

    Recruiting
    • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
    • Basic chemotherapy + UCB transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 9, 2022

    Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Tagraxofusp (Cycles 1-2)
    • +2 more
    • (no location specified)
    Jun 28, 2022

    Acute Myeloid Leukemia Trial in Heidelberg (Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib)

    Terminated
    • Acute Myeloid Leukemia
    • Gemtuzumab Ozogamicin 147
    • +3 more
    • Heidelberg, Baden-Württemberg, Germany
      University Hospital Heidelberg, Internal Medicine V
    Jun 27, 2022

    Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

    Recruiting
    • Newly Diagnosed Acute Myeloid Leukemia (AML)
    • SKLB1028 Dose Escalation
    • Chengdu, China
      West China Hospital of Sichuan University
    Jun 30, 2022

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

    Available
    • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
    • (no location specified)
    Oct 18, 2022

    Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

    Completed
    • Acute Myeloid Leukemia (AML)
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Jul 27, 2022

    Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Chicago, Illinois
      University of Illinois at Chicago
    Jul 1, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Jan 19, 2023

    Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • AML Stage, Adult
    • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
    • Xiamen, Fujian, China
      Bing Xu
    Oct 29, 2022

    Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +7 more
    Mar 27, 2022